Forward looking approaches & its Experiences of PMDA's ATC

Similar documents
International trend on medical device regulatory convergence

Role and Vision of PMDA

Consideration on Global Harmonization

Regional Alignment in Asia Pacific -

International Trend on Medical Device Regulatory Convergence

International Medical Device Regulatory Harmonization. Reality or Fantasy?

Direct Patient ADR reporting system in Japan. Kazuhiko Mori, Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Evolution and achievements of ICH- GCG (Global Cooperation Group)

PMDA Update: Its current situation

PMDA EPOCH Toward 2020

ICH Regulators Forum. Dr Peter Arlett EU

Progress Report in 2016

Recent Development of ICH GCG

Role and Activities of NGO on Export Control. Hiroshi NAKAO Center For Information On Security Trade Control (CISTEC) JAPAN

Tomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan

Policy Recommendation of the AEM-MITI's Working Group on Economic Cooperation in Cambodia, Laos and Myanmar Phnom Penh, 23 August 1996

GCP Inspection by PMDA

Mid-term Targets of the Pharmaceuticals and Medical Devices Agency (PMDA) *(Provisional Translation)

Work plan for GCP Inspectors Working Group for 2018

Issue 7/ Jul - Sept 2012

Expectation and Demands of Clinical Trial Capacity from Overseas-Status quo of Taiwan

Portland, Oregon, USA (Portland Marriott Downtown Waterfront Hotel)

New Streams of Risk Management. Tomiko TAWARAGI Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA)

Toward Greater Scientific Rigor

Trends in the development of regulatory systems by the example of ICH countries

Yokohama, Japan (Yokohama Royal Park Hotel)

Why do we need an addendum to ICH E6?

Training components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA

FINAL STATEMENT BY THIRD APEC HIGH LEVEL MEETING ON HEALTH AND THE ECONOMY

Regional Update ASEAN PPWG

IVD/MD Asian Working Group Emerging Market Research Report No.2

Pharmacovigilance in Japan and Risk Management Plans(RMP); Regulator Perspective

The Japan Council of Local Authorities for International Relations (J.CLAIR), Singapore

Food Safety Capacity Building: The role of public private partnerships

2012/SMEMM/010 Agenda Item: 2.4. SMEWG Chair Report. Purpose: Information Submitted by: SMEWG Chair

Audit and Inspection

Hong Kong Association of Gerontology Seminar cum Launching Ceremony of Territory Wide Carer Support Network

JICA Technical Cooperation Project: Activities and outcomes. Satoshi Iemoto

Grant Program for Intellectual Exchange Conferences Application Instructions

WYSIWYG CO., LTD. October 2015

Health in APEC Creating economic prosperity through strategic health care investments and enabling environments for business

A SHARING ON REGULATORY TRAINING EXPERIENCE IN ASIA JACK WONG

Hong Kong Quality Assurance Agency Symposium May 2018 Build a Sustainable City with Innovation, Artificial Intelligence and Technology

Pharmacovigilance: The patient s Perspective. Souzi Makri Chairperson AGORA EUPATI Fellow Executive Secretary CYPLAR President ENFA

Regional Update ASEAN PPWG

The place of the Certification procedure in 2017 in the EU regulatory framework and beyond. Prague, 19 September 2017

Waseda University s Global Engagement Strategy

Outline of Collaborative R&D Project for Disaster Mitigation on Network of Research Institutes

Update on FDA-EMA QbD Pilot

Strategic Fund for Establishing International Headquarters in Universities (SIH) FY2007 Open Symposium

Evaluating adverse events from patient support and market research programs: proposed best practices and regulatory changes

Quality Risk Management ICH Q9

Current status on Adverse Event Reporting in Japan

Engaging with the Internet Society An update on activities in the Asia-Pacific

SUMMARY REPORT OF THE 17 th ACCSQ MDPWG MEETING

2016/SOM2/025 Agenda Item: CTI Chair s Report. Purpose: Consideration Submitted by: CTI Chair

APEC Telecenter Development Program

APEC Subcommittee on Standards and Conformance

Business Opportunities for Czech Companies on Japanese Market. Stanislav Beneš Commercial Counsellor MFA Prague, 17 th April 2018

IFRS Foundation Asia/Oceania office: Assisting the region in global convergence

A Workshop on the Comparability of Qualifications in the Health Sector within the APEC Region APEC Project HRD 07-06A SUMMARY REPORT

Small Grant Program. Program Guidelines

Establishment of Regional Database on Herbal Medicine

II. OPERATION RESULTS / ACHIEVEMENT OF FY 2005

Regulatory Networks. Regulatory Capacity Building Workshop: Vaccine Clinical Trial Review from Ebola to HIV March 2015 Kigali, Rwanda

Engaging Global Stakeholders to Expand Access to the LNG-IUS. Sally Stephens, Senior VP, Corporate Development, Medicines360

Pharmaceutical Industry

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

How to bridge the standardization gap

CSSD. Center of Excellence Program

of Study Abroad Programs Operated by Overseas Universities.

Enhancing SME Global Competitiveness

Accelerated procedure for registration of WHO-prequalified medicines = Collaboration Procedure between the WHO Prequalification Programme and NMRAs

APEC LSIF Blood Supply Chain Initiative Overview

Presentation by Julie Sinnamon, CEO Enterprise Ireland. 22 nd November 2016

This document is being disclosed to the public in accordance with ADB s Public Communications Policy 2011.

IMDRF Project: List of international standards recognized by IMDRF management committee members

Observers Takuya Noro MHLW X X X Hideto Yokoi PMDA Advisor X X X Adriana Gamboa INFARMED X X X

Global Innovation from Tokyo

ICH STEERING COMMITTEE October 24-29, 2009 St. Louis, MO, USA SUMMARY

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Regional Update ASEAN PPWG

Empowering Women as Managers in the Renewable Energy Sector. An Asia Pacific Economic Cooperation (APEC) project

APEC Food Safety Cooperation Forum

APEC Blood Supply Chain Roadmap

Environmental Management. Respect for Human Rights. Nikon Community Contribution Activities Policy

Engaging with the Internet Society An update on activities in the Asia-Pacific

Annex Template for the call for input

Accessibility in Information and Communication Technology

Good Governance for Medicines Medicines as part of Universal Health Coverage

Center of Excellence Program. APAC COE Program Brochure A4 8pp 2017.indd 1

I. General Description. I-1. Joint Funding of Multilateral Research Cooperation

Information Brochure Professional Certificate in Pharmacovigilance

OCTOBER 11-14, 2018 Beijing, China mcdonnellsymposium.wustl.edu

Scholarship Information

Corporate Governance Program East Asia and the Pacific. Annual Summary 2016 IN PARTNERSHIP WITH

Report on APEC-Funded Medical Device Delegation Visit Program to Australia, and Canada and the United States

Oumkaltoum Lahlou Head of Regulatory Affairs North & West Africa, Merck Group, Darmstadt, Germany

Helping you capture new markets

Annual report of the Good Clinical Practice Inspectors Working Group 2016

Transcription:

6 th Asia Partnership Conference of Pharmaceutical Associations, Tokyo, 5 th April 2017 Forward looking approaches & its Experiences of PMDA's ATC Junko Sato, PhD Office Director, Office of International Cooperation, PMDA sato junko@pmda.go.jp 1

PMDA International Strategic Plan 2015

Introduction PMDA International Strategic Plan 2015 PMDA s primary responsibility: Providing a reliable environment which affords quicker access to more effective and safer medical products Change of environment surrounding PMDA: Globalization of research, development, manufacture, and distribution of the products, Expectation to PMDA for International Contribution VISION I To contribute to the world through regulatory innovation 3 Visions Vision II To maximize the common health benefits to other countries/regions Vision III To share the wisdom with other countries/regions Strategy 1:Taking the lead, and disseminating the information around the globe With be Established Regulatory Science Center Strategy 2: Promotion of international regulatory harmonization and global cooperation Strategy 3: Increase efficiency of inspections that may lead to future international work sharing Strategy 4: Contribution to international regulatory harmonization activities 5 Strategies Strategy 5: Provision of information and training programs that are essential for building regulatory capacity in partner countries With be established Asian Training Center Cultivation of human resources Strengthening of translation, dissemination of information, and information analysis Solid basis to implement strategies 3

Asia Training Center for Pharmaceuticals and Medical Devices Regulatory Affairs (PMDA ATC) Established on 1 April, 2016 4

Asia Training Center for Pharmaceuticals and Medical Devices Regulatory Affairs Plan, design and coordinate training for Asian regulatory authority staff Provide training opportunities including on site training Help raise the level of regulations in Asia as a whole. Asia Training Center (within PMDA) Japan (1) Training seminar by PMDA, local prefectures and industry Local Asian site (2) Assign to local site APEC (3) APEC Training Centre for Clinical Trial and Pharmacovigilance 5

PMDA ATC seminars held in FY2016 Theme Date Place Participants 1 Pharmaceuticals Review July 25 29, 2016 Tokyo (PMDA) 13 from 7 countries/regions 2 PharmaceuticalsReview September 26 29, 2016 3 Medical Device November 7 11, 2016 4 Good Registration Management (GRM) 5 Good Manufacturing Practice (GMP) Inspection* 6 Multi Regional Clinical Trial (MRCT)** November 15 17, 2016 December 5 9, 2016 January 23 26, 2017 7 Pharmacovigilance** February 6 9, 2017 Bangkok *With the support of PIC/S, **APEC LSIF RHSC CoE Pilot Workshop 13 from Hong Kong and Thailand Tokyo (PMDA) 28 from 13 countries/regions Taipei 28 from 10 countries/regions Toyama 19 from 12 countries/regions Tokyo (PMDA) 32 from 14 countries/regions Tokyo (PMDA) 28 from 15 countries/regions 6

PMDA ATC seminars planned in FY2017 Theme Date Place 1 Risk Management Plan (RMP) May 18 19, 2017 Jakarta 2 Pharmaceuticals Review June 26 30, 2017 Tokyo (PMDA) 3 Good Manufacturing Practice (GMP) Inspection* July 31 August 4, 2017 Hikari 4 Anti infective October, 2017 Hanoi 5 Medical Device November, 2017 Tokyo (PMDA) 6 Good Registration Management (GRM) November, 2017 Taipei 7 Pharmaceuticals Review December, 2017 Bangkok 8 Multi regional Clinical Trial (MRCT)** January, 2018 Tokyo (PMDA) 9 Pharmacovigilance** February, 2018 Tokyo (PMDA) *With the support of PIC/S, **APEC LSIF RHSC CoE Workshop 7

Project Teams established by PMDA staffs Pharmaceuticals Review Review Offices GMP Inspection* With the support of Pharmaceuticals Review in Thailand Medical Devices Standards Office Compliance Offices Safety Offices Relief Funds Office Good Review Management Multi Regional Clinical Trial Pharmacovigilance 8

What we do at PMDA ATC Organize Training programs held at PMDA and overseas Exchange staff members for on-the-job training Training themes: Best Regulatory Practices in Product Review, Safety Info Analysis, etc. ICH, IMDRF, IGDRP, ICCR, PIC/S Guidelines Specific topics per request by partner country 9

Purpose of PMDA ATC Well Communication Information/Experience sharing based on other regulator s needs Building trust relationship with Asian regulators to work for Asian citizen Win Win relationship 10

Our plans for the future 1. Continue holding PMDA ATC Seminars at PMDA. 2. Increase the number of PMDA ATC Seminars held Japan/overseas to provide more chances to train the trainer. 3. Plan PMDA ATC Seminars with more flexibility. theme, duration, mock review etc. 4. Conduct hearings to find out the training needs. 5. Work collaboratively with training providers for regulatory convergence 11

PMDA future direction in Asia Disseminate PMDA s accumulated knowledge and experiences to promote regulatory science. Provision of hints for betterment of the regulations in participants' regulatory authority. More contribution to public health as a result of improvement in regulations. PMDA will contribute to promote Capacity Building Activities in Asia

PMDA Future direction PMDA Knowledge & Experience Public Health in Asia Level of Regulation in Asia 13

PMDA will contribute to promote Capacity Building Activities in Asia PMDA ATC activities Bilateral Meeting APEC CoE Symposium, Trainings 14